Nanogels with volume phase transition for biomedical applications Authors: Zheng Li, Xiangliang Yang, Zifu Li Published: 2025 ABSTRACT Nanogels, of which the three-dimensional network structures are covalently crosslinked by crosslinkers and supported by large number of hydrogen bonds, present unique volume phase transition (VPT) and play significant roles in multiple biomedical applications. Based on hydrogen bonds, the VPT features including the shift, sharpness, and range of VPT, can be rationally designed and precisely controlled by simply regulating the monomer, comonomer, crosslinker, structure, deuteration, environmental stimuli, and so on, for tailored biomedical applications such as transcatheter arterial embolization (TAE) and tumor targeting drug delivery (TTDD). Moreover, the exploration of the minimum value of physicochemical properties around volume phase transition temperature (VPTT) exhibits great potential in improving current tumor therapies and developing more therapeutic strategies. Integrating systematic knowledge of nanogel VPT properties, we provide the guidance for rational design of nanogels with tailored biomedical applications. Introduction Nanogels, also termed hydrogel nanoparticles, have received tremendous attention for biomedical applications1,2. Great strides have been accomplished in fundamental studies of temperature-responsive polymers, e.g., poly(N-isopropylacrylamide) (PNIPAM), poly(N-isopropylmethacrylamide) (PNIPMAM), or poly(N-vinyl caprolactam) (PVCL), which display lower critical solution temperature (LCST), shedding light on uncovering the mechanism of nanogels’ volume phase transition (VPT) (Box 1)3–5. Typical three-dimensionally crosslinked polymeric networks dispersed in water of nanogels are determined by intramolecular and intermolecular hydrogen bonds, while the VPT of nanogels is the transition between hydrophilicity and hydropgobicity6,7. Accordingly, by regulating the monomer, comonomer, crosslinker, structure, deuteration, and environmental stimuli of nanogels, the volume phase transition temperature (VPTT) can be elevated or reduced, the VPT process can be sharpened or smoothed, and the range of size variation can be broadened or narrowed8–10. Here, we summarize the progress on nanogels’ VPT and expound the correlation between nanogel design and VPT regulation (Fig. 1).Fig. 1The rational design of nanogel VPT for tailored biomedical applications in TAE and TTDD.Relying on the variation of intramolecular hydrogen bonds (dotted line), the monomer, comonomer, crosslinker, structure, deuteration, and environmental stimuli of nanogels can be regulated for three vital modulations of VPT behaviors, including shift, sharpening, and broadening. In detail, the parameters of nanogels are listed from top to bottom according to their significance in individual modulations of VPT, among which the primary parameters are demonstrated at the top. Therefore, the VPT of nanogels can be rationally designed to satisfy distinct biomedical applications in TAE and TTDD. The rational design of nanogel VPT for tailored biomedical applications in TAE and TTDD. Relying on the variation of intramolecular hydrogen bonds (dotted line), the monomer, comonomer, crosslinker, structure, deuteration, and environmental stimuli of nanogels can be regulated for three vital modulations of VPT behaviors, including shift, sharpening, and broadening. In detail, the parameters of nanogels are listed from top to bottom according to their significance in individual modulations of VPT, among which the primary parameters are demonstrated at the top. Therefore, the VPT of nanogels can be rationally designed to satisfy distinct biomedical applications in TAE and TTDD. Ranging from several to hundreds of nanometers, nanogels not only demonstrate the advantages of conventional nanoparticles but also exhibit the superiorities of bulk hydrogels in biomedical applications. Compared with other types of nanoparticles, nanogels have a distinctive architecture with solvent permeability, rendering complicated interactions between adjacent nanogels11,12. In essence, crosslinked nanogels are polymer networks with colloid-polymer duality, which not only dictates the interaction forces between adjacent nanogels but also regulates nanogel dispersion properties13,14. In particular, in concentrated suspension, nanogel dispersions show complex rheological properties, which could be employed for specific usages, for instance, transcatheter arterial embolization (TAE)15–17. Owning porous structure and multiple functional groups, nanogels display rapid VPT on the microsecond time scale to subtle changes of environment, e.g., temperature, pH, and ionic strength, probably relying on fast crumpling and collapsing of polymer chains in the incompact periphery of nanogels, while the VPT of their bulky analogs takes hours or days18–20. Accordingly, nanogels exhibit unique sensitivity to biological environments and precise stimuli-triggered drug release, which are highly desirable for tumor targeting drug delivery (TTDD)21. Besides, nanogels are highly deformable and greatly potent in crossing various biological barriers and regulating various cellular behaviors10,14,22,23. Therefore, the VPT of nanogels should be delicately designed and controlled to satisfy varied application scenarios and conditions in TAE and TTDD, such as gelation degree, responsive speed, and deformability. Here, we aim to provide guidance for the rational design of nanogel VPT with tailored biomedical applications (Fig. 1). Based on the variation of intramolecular hydrogen bonds, the VPT of nanogels can be shifted, sharpened, and broadened by simply adjusting the monomer, comonomer, crosslinker, structure, deuteration, and environmental stimuli. Furthermore, recent investigations have begun to expand our knowledge on nanogels’ VPT in bulk solution and at air/water and oil/water interfaces24–26. Nanogels with a unique network structure exhibit sensitive VPT with stimuli responsiveness, which is a complex transformation of hydrophilicity, size and conformation, ascribing to coordinate interactions among hydrogen bonds, electrostatic interaction, network rigidity, and so on3. As a result, specific physical parameters, including radius of gyration (Rg), hydrodynamic radius (Rh), bulk modulus (K), Young’s modulus (E) of nanogels and interfacial tensions (γ) of nanogel-stabilized emulsions vary synchronously during VPT and intriguingly possess a minimum value around VPTT. Such variations of nanogels might also contribute to biomedical applications27,28. First, the minimum Rg/Rh and K may optimize the sol-gel transition kinetics of TAE agents and enhance the flowability during injection as well as embolization strength at the target area. Second, the minimum E may endow the nanogel with superior deformability for overcoming biological barriers and sufficient TTDD. Third, the minimum γ might enhance the stability of nanogel-stabilized emulsions for strengthened TAE, or efficient TTDD of hydrophilic or hydrophobic drugs. These peculiarities of nanogel VPT present great potential for applications in TAE, TTDD, and so on29. Nanogels are deformable hydrogel nanoparticles that consist of chemically or physically crosslinked three-dimensional polymer networks dispersed in aqueous solution. One unique feature of nanogels is their stimuli-responsive volume phase transition (VPT), manifesting in the process of swelling and collapsing. Typical nanogels with VPT properties are based on poly(N-isopropylacrylamide) (PNIPAM), poly(N-isopropylmethacrylamide) (PNIPMAM), and poly(N-vinyl caprolactam) (PVCL). Such VPT behavior can be shifted, sharpened and broadened via the regulation of the monomer, comonomer, crosslinker, structure, deuteration, and environmental stimuli of nanogels, playing a significant role in biomedical applications, such as transcatheter arterial embolization (TAE) therapy, tumor targeting drug delivery (TTDD), to name a few. Regulating nanogel volume phase transition One of the widely studied and understood polymeric nanogels exhibiting a particular volume phase transition process (Box 1)30,31 is based on PNIPAM. It is widely accepted that the intramolecular hydrogen bonds are the predominant factor, affected by parameters including the monomer, comonomer, crosslinker, structure, deuteration, environmental stimuli, and so on (Fig. 1), synergistically determine the volume phase transition process of nanogels32. Traditionally, the VPT process has been studied by measuring the variation of Rh, which is defined as the radius of an equivalent hard sphere diffusing at the same rate under observation3. Such VPT variations exhibit in the shift of VPT, the sharpness of VPT, and the range of VPT, making a great contribution to specific biomedical applications10,33. In the following parts, we will introduce progresses on nanogels’ VPT behaviors, mostly based on PNIPAM nanogels, and their biomedical applications in TAE and TTDD. Shift of VPT The shift of VPT is usually considered as the increase or decrease of the VPTT of nanogels via different approaches, as a result of varied interactions between hydrophilicity and hydrophobicity, Fig. 1. An important factor in regulating nanogel VPT is the hydrophobicity of comonomers. At temperatures above VPTT, the hydrogen bonds become unstable or broken, and the hydrophobicity is enhanced, leading to the transition of nanogels from a hydrated swollen state to a dehydrated shrinking state. Accordingly, the addition of hydrophobic monomer N-tert-butylacrylamide (BAM) obtaining NIPAM and BAM copolymerized nanogels (PNT NGs) shifts the VPTT of PNIPAM nanogels to a lower value34. In addition, hydrophobic comonomer butyl methylacrylate (BMA) could lower the VPTT of PNIPAM nanogels from 32.9 °C to 29.2 °C. In contrast, the hydrophilic comonomer acrylamide (AAm) increased the VPTT to 37.8 °C33. In replacement of the comonomer acrylic acid (AA) with more hydrophobic comonomer 3-aminophenylboronic acid (AAPBA), the VPTT of PNIPAM nanogels was decreased20. Consistently, the hydrophobic comonomer 2-hydroxy-4-(methacryloyloxy)-benzophenone (HMABP) decreased the VPTT of PNIPAM nanogels35. The second approach is the introduction of comonomers, whose polymers possess varied LCST. By regulating the content ratio of temperature-sensitive polymers with different LCST, the VPTT of PNIPAM-based nanogels (32 °C) could be tailored to other temperature regions. In detail, the VPTT of PNIPAM nanogels could be decreased by the addition of N-n-propylacrylamide (NNPAM) to around 22 °C or lifted by NIPMAM to around 45 °C. Meanwhile, higher content of comonomers led to stronger shift of VPTT, but no more than the LCST of corresponding polymers8. Furthermore, the copolymerization with VCL led to a negligible influence on the VPTT of PNIPAM nanogels, but gradually decreased the VPTT of PNIPMAM nanogels with increased content of VCL36. There were also specific situations that the VPTT of copolymerized nanogels was not linearly correlated to the molar ratio of comonomers due to complexed hydrogen bonds. For instance, the comonomer N,N-diethylacrylamide (DEAAM) could nonlinearly decrease the VPTT of PNIPMAM nanogels. However, in PDEAAM-PNIPAM nanogels, the VPTT reached the lowest value when the monomer content of DEAAM was around 60 wt%37. In contrast, because of the chemical similarity of BAM to NIPAM and the intramolecular hydrogen bonds were comparable, the decrease of VPTT was monotone, and no minimum value was observed in the hydrogels prepared with the increase of BAM content9. Additionally, deuteration of monomers or solvents also varies the hydrogen bonds and further affects the VPT of nanogels. The VPTT of nanogels usually presented a shift of 3–8 K to higher temperature after deuteration, and the shifting extent was determined by monomer types and deuterated level38,39. After deuteration, the solvent-polymer interactions became stronger than polymer-polymer or solvent-solvent interactions, leading to increased VPTT. Meanwhile, the weakened intramolecular hydrophobic interactions by deuteration further shifted VPTT to a higher region40. It was reported that the VPTT of partially deuterated PNIPAM nanogels shifted by 8.4 K compared to fully hydrogenated nanogels, whereas fully deuterated nanogels shifted by only 5 K, because of more efficient disruption of solvent-polymer hydrogen bonds. Furthermore, the higher content of deuterated comonomers also contributed to the shift of VPTT from 45 °C to 53 °C38. In addition to deuteration of monomers, the deuteration of solvent could decrease the VPTT of nanogels to a certain extent, which was concurrently determined by the deuterated level of nanogels, owing to the varied hydrogen bonds38. Finally, other environmental stimuli in solution also play a role. The incorporation of Iohexol® (a nonionic X-ray contrast agent) with a large number of hydrophilic groups increased the VPTT of PNIPAM nanogels to 46 °C. So, the copolymerization with hydrophobic BMA could decrease the VPTT of nanogel back to 36.5 °C for in vivo sol-gel transition and embolization33. For nanogels with pH-sensitive groups such as P(NIPAM-AAPBA) nanogels, the higher pH of the solution induced stronger dissociation of phenylboronic acid (PBA) groups and increased VPTT20. In summary, the vital importance of intermolecular and intramolecular hydrogen bonds is undoubted to the shift of VPTT, which can be precisely controlled via the introduction of comonomers with varied hydrophobicity or polymers with different LCST, the deuteration of monomers or solvent and so on (Fig. 1). Sharpness of VPT Owing to the large number of amide groups and isopropyl groups in polymer networks, pure PNIPAM hydrogels or nanogels exhibited a specific, sharp and steep transition from hydrophilic to hydrophobic state with an increase in temperature. The temperature-scale sharpness of VPT is affected by several factors, including the comonomer, crosslinker, structure, and deuteration of nanogels, as presented in Fig. 1. It was reported that hydrophobic comonomer HMABP could broaden the VPT process of PNIPAM nanogels and that no VPT could be observed when the content of HMABP was above 9 mol%. Moreover, the temperature-sensitivity was lost with HMABP above 12 mol%35. Similarly, increased BAM content significantly broadened the VPT process of PNIPAM nanogels9. The comonomer DEAAM could smooth the VPT process of PNIPAM nanogels, while the sharpest transition appeared at 60 wt% of DEAAM41. While the temperature-responsive VPT is rapid, the complicated intramolecular interaction of nanogels can be utilized to slow down the VPT process. For example, the large steric hindrance from the N-tert-butyl side group of butyl methylacrylate could retard the dehydration of hydrophobic alkyl groups and sharp VPT of PNIPAM nanogels34. Furthermore, the network density and rigidity hinder the VPT process of nanogels. Higher content of crosslinker N,N’-methylenebisacrylamide (BIS) endowed PNIPMAM nanogels with increased rigidity and broadened VPT42. Not only the shift of VPT but also the sharpness of VPT is affected by nanogel deuteration. Compared with fully hydrogenated nanogels, fully deuterated PNIPAM nanogels exhibited sharper and steeper VPT behaviors as a function of temperature, but the partially deuterated ones possessed the broadest and mildest transition, due to varied intramolecular hydrogen bonds38. The sharpness of nanogel VPT also exhibits in time scale, which is mainly influenced by comonomer and environmental stimuli, Fig. 1. The collapse time of PNIPAM nanogels was prolonged from 0.45 μs to 1.5 μs when 2 mol% of hydrophobic BMA was introduced to the shell. However, no variation of the collapse time was observed with the introduction of BMA to the core, indicating that the collapse time of nanogels is mainly governed by the shell of nanogels and could be regulated by the addition of hydrophobic comonomers to the shell18. Higher content of AAm in PNIPAM nanogels resulted in more time requirement for equilibrium deswelling and less time requirement for swelling43. In P(NIPAM-AAPBA) nanogels, the glucose-induced swelling could prolong the time scale of VPT to 102 s, compared to the temperature-induced swelling of PNIPAM nanogels with a VPT time scale from 100 ns to tens of milliseconds. Similarly, the pH of the solution also affected the VPT kinetics of P(NIPAM-AAPBA) nanogels due to the varied concentration of hydrogen ions20. Compared to the VPT of a single nanogel, the sol-gel transition kinetics of collective nanogels attract higher attention. Owing to moderative shrinkage of nanogels, the hydrophobic interactions among PNT NGs contributed to a faster sol-gel gelation than dehydration of nanogels, leading to more rapid gelation of PNT NGs than phase separation. As a result, the addition of BAM decreased the gelation temperature and critical gelation concentration of PNT NGs. Furthermore, a higher concentration of PNIPAM nanogels contributed to less time cost for the sol-gel transition34. Not only the concentration of nanogels but also the interval between the initial temperature and the terminal temperature determined the sol-gel transition kinetics, and a narrower interval led to faster gelation33. In summary, the temperature-scale and time-scale sharpness jointly determined the speed of nanogel VPT, to satisfy the requirement for specific biomedical applications (Fig. 1). Range of VPT The range of nanogel VPT is characterized as the ratio between the maximum Rh or volume at hydrophilic swelling state and the minimum Rh or volume at hydrophobic shrunken state, also closely correlated with other parameters such as deformability or stiffness14. First, the regulation of crosslinking density is the most valid and adopted method, which directly restricts the swelling or collapsing capacity and the range of nanogel VPT, as a result of increased polymer network stiffness. When the crosslinking density of PNIPMAM nanogels increased from 2% to 15%, the temperature-sensitive volume change ratio of nanogels decreased from 10.62- to 1.92-times. Such variation is also reflected in another parameter, as stiffness, from 79.0 kPa for soft 2%-crosslinking nanogels to 439.2 kPa for 15%-crosslinking nanogels10. It was also confirmed that a higher content of crosslinker BIS led to a reduced swelling ratio of Rh from 2.1 to 1.5 in PNIPAM nanogels44. The structure of nanogels also affected the range of VPT. As an example, in core-shell PNIPAM nanogels with silica core, the shrinkage of PNIPAM shell was obviously restricted by the support from silica core, but the hollow PNIPAM nanogels presented obvious collapse at VPTT after dissolution of silica core45. Besides, in PNIPMAM-PNNPAM core-shell nanogels, the VPT became more complicated because of the “corset-effect” of the shell. A two-phase VPT was observed, including the swelling of PNIPMAM core at the temperature below the VPTT of PNIPMAM nanogels (45 °C), which was restricted by the PNNPAM shell with VPTT of 22 °C, and the joint swelling of the whole PNIPMAM-PNNPAM nanogels below 22 °C. It should be mentioned that PNIPMAM-PNNPAM nanogels exhibited a linear VPT between 45 °C and 22 °C, and the VPT range was varied in a certain temperature interval46. Moreover, because of the “corset-effect”, higher shell crosslinking density or thickness led to stronger restriction to swelling or shrinkage of the core47. In addition, the type of comonomers is another factor determining the range of VPT. The introduction of comonomer HMABP obviously suppressed the swelling ratio of PNIPAM nanogels. When the content of HMABP reached 12 mol%, the hydrodynamic radius of PNIPAM nanogels almost kept constant at varied temperatures35. The comonomer dimethylaminoethyl methacrylate (DMAEMA) also decreased the swelling ratio of PNIPAM nanogels. However, when the content of DMAEMA was over 1%, the swelling ratio reversely increased28. The range of nanogel VPT also varied with other environmental stimuli, instead of temperature. The PBA groups of P(NIPAM-AAPBA) nanogels converted to being negatively charged and hydrophilic from a neutral and hydrophobic state after conjugation with glucose, resulting in the gradual swelling of P(NIPAM-AAPBA) nanogels. Such glucose-induced swelling was positively correlated with the concentration of glucose20. Besides, the pH-induced VPT of PNIPMAM nanogels with 2% crosslinking density exhibited a weaker volume swelling ratio of 5.7 times, compared to 10.62 times of temperature-induced VPT, whereas the pH-induced and temperature-induced volume swelling ratios of PNIPMAM nanogels with 15% crosslinking density were 2.18 times and 1.92 times, respectively10. Collectively, in addition to the predominance of crosslinking density, the structure of nanogels also plays an important role in the deformation and VPT range of nanogels. Meanwhile, the introduction of different monomers varying the intramolecular interactions or the utilization of discrepant stimuli-responsive capacity of nanogels also leads to a distinct VPT range (Fig. 1). In summary, by regulating the monomer, comonomer, crosslinker, structure, deuteration, and environmental stimuli of nanogels, the VPT features of nanogels, such as the shift, sharpness, and range of VPT, could be rationally designed and precisely controlled, offering convenient means for tailored biomedical applications. Correlating nanogel volume phase transition with biomedical applications While the correlation between nanogel design and VPT behaviors has been expounded above (Fig. 1), how the regulation of VPT impacts biomedical applications awaits further analyses. In the following parts, we will discuss the biological utilization potential of shift, sharpness, and range of nanogel VPT, especially in TAE and TTDD. Shift and sharpness of VPT for TAE and TTDD As the volume fractions of PNIPAM nanogels could be easily tuned by changing temperature across VPTT, rheological behaviors of PNIPAM nanogels have attracted tremendous attention since 199948,49. As an interventional therapy, TAE leverages a catheter to selectively and directly deliver embolic agents to targeted arteries under the guidance of imaging instruments to embolize blood vessels and achieve localized drug administration15,16,50,51. To ensure the feasibility and safety of TAE, VPTT of nanogels is concerned and shifted to a certain temperature region to balance conflicting requirements between flowability and embolization strength. Meanwhile, the sharpness of nanogel VPT represents the sensitivity to stimuli, which is also relevant to TAE efficacy and safety. In 2011, Zhao et al. reported the preparation of poly(N-isopropylacrylamide-co-butyl methylacrylate) (PIB) nanogels as an effective embolic material together with Iohexol®, which underwent an interesting phase diagram of swollen gel, flowable sol, and shrunken gel with increasing temperature, from excellent flowability to high mechanical strength across VPTT, for TAE therapy against liver tumors (Fig. 2)33. Such sol-gel transition kinetics could be tuned properly by controlling the VPTT of PIB nanogels for successful TAE therapy. To decrease the VPTT of PNIPAM nanogels after the addition of Iohexol®, the hydrophobic comonomer BMA was introduced to obtain PIB nanogels with a VPTT of 36.5 °C33. Meanwhile, the appropriate VPT speed of PIB nanogels was vital for successful TAE therapy, instead of a too fast sol-gel transition blocking the catheter or a too slow sol-gel transition leading to lethally errant embolization15. Such temperature-triggered sol-gel transition of PIB nanogel suspensions overcame the limitations of both liquid embolic agent Lipiodol® and solid embolic material Ivalon®33. Li et al. further optimized PIB nanogel compositions to obtain a complex dispersion with only a quarter of Lipiodol® viscosity as low as 22 mPa·s at 25 °C, which presented exceptional flowability and occluded all eight levels of micro-channels in a tumor vessel mimetic model52. So, the VPTT of nanogels can be optimized to regulate the kinetics of the VPT process, achieving efficient embolization of capillaries and avoiding ectopic embolization in different organs or blood vessels. Accordingly, the shortcomings of TAE therapy, like tumor collateral circulation and vascular re-canalization, could be suppressed by simply regulating nanogel VPT.Fig. 2Appropriate shift and sharpness of nanogel VPT for successful TAE therapy.PIB-I-6150 with VPTT of 36.5 °C and appropriate speed of sol-gel transition demonstrates significant advantages over Ivalon® and Lipiodol® in permanent and peripheral embolization, for successful TAE therapy against liver tumors. Reprinted with permission from ref. 33. Copyright 2011 Wiley. Appropriate shift and sharpness of nanogel VPT for successful TAE therapy. PIB-I-6150 with VPTT of 36.5 °C and appropriate speed of sol-gel transition demonstrates significant advantages over Ivalon® and Lipiodol® in permanent and peripheral embolization, for successful TAE therapy against liver tumors. Reprinted with permission from ref. 33. Copyright 2011 Wiley. The shift of nanogel VPT, which depends on pH-triggered adaptive hydrophobicity, plays a crucial role in tumor-targeting drug delivery. For instance, comonomer N-methylallylamine provided PNIPAM-based nanogels SNG with pH-responsiveness, of which the VPTT was ~37.5 °C at pH 7.4 and rapidly switched to ~36.1 °C once the solution pH was lowered to ~6.5 (Fig. 3)53. Therefore, SNG was hydrophilic in the blood stream for prolonged circulation but turned to be hydrophobic in the acidic tumor microenvironment (TME), facilitating TTDD53,54. The concept of pH-triggered adaptive hydrophobicity had also been employed to deliver DOX and magnetic nanoparticles with poly(oligo(ethylene glycol) methacrylates-co-acrylic acid) and PNIPAM nanogels, respectively55,56.Fig. 3pH-triggered shift of nanogel VPT for sufficient TTDD.pH-responsive hydrophobicity-adaptive nanogels possess VPTT of ~37.5 °C at pH 7.4 with hydrophilicity for prolonged blood circulation, and VPTT of ~36.1 °C at pH 6.5 with hydrophobicity for effective tumor delivery. Adapted with permission from ref. 53. Copyright 2018 American Chemical Society. pH-triggered shift of nanogel VPT for sufficient TTDD. pH-responsive hydrophobicity-adaptive nanogels possess VPTT of ~37.5 °C at pH 7.4 with hydrophilicity for prolonged blood circulation, and VPTT of ~36.1 °C at pH 6.5 with hydrophobicity for effective tumor delivery. Adapted with permission from ref. 53. Copyright 2018 American Chemical Society. Tailoring nanogels VPT for TTDD As mentioned above, the nanogel VPT is essential to TAE therapy (Fig. 2), while the transition between hydrophilicity and hydrophobicity is relevant to tumor targeting drug delivery (Fig. 3). Relying on nanogel VPT, some distinctive strategies have been developed for TTDD applications57,58. In these cases, heat is utilized to initiate the hydrophilicity-to-hydrophobicity transition in nanogels. For instance, platinum nanocomplexes or mesoporous silica capped gold nanorods were coated with PNIPAM polymers to yield hybrid nanogels, which were hydrophilic for prolonged blood circulation but turned to be hydrophobic for efficient TTDD and drug release after photothermal therapy by 808 nm laser (Fig. 4)57,59. In contrast, the hydrophobicity-to-hydrophilicity transition of P(NIPAM-BAM) nanogels was exploited for cooling-induced and localized release of cytotoxic peptides for cancer therapy58. Since the binding affinity between nanogels and proteins, such as lysozyme, changed evidently at varied temperatures60,61, P(NIPAM-BAM) nanogels caught lysozymes at temperatures above VPTT but released lysozymes below VPTT. Similarly, a P(NIPAM-BAM) nanogel with VPTT below 25 °C had a high affinity with melittin at physiological temperature but rapidly released melittin upon cooling of the tumor58.Fig. 4NIR laser induced VPT of nanogels for TTDD.The shrinkage and drug release of PNIPAM-coated nanocomposites, which transfer from hydrophilic formations to hydrophobic ones, are activated by 808 nm laser, contributing to effective tumor targeting thermo-chemotherapy. Reprinted with permission from ref. 59. Copyright 2014 American Chemical Society. NIR laser induced VPT of nanogels for TTDD. The shrinkage and drug release of PNIPAM-coated nanocomposites, which transfer from hydrophilic formations to hydrophobic ones, are activated by 808 nm laser, contributing to effective tumor targeting thermo-chemotherapy. Reprinted with permission from ref. 59. Copyright 2014 American Chemical Society. Compared to the shift and sharpness of VPT, the range of nanogel VPT is more relevant to nanogel deformability or stiffness, playing a significant role in nanogel-cell and nanogel-organ interactions for TTDD16,27,54. For nanogel-cell interactions, Switacz et al. demonstrated that smaller and less crosslinked PNIPAM nanogels exhibited faster uptake by HEK293T cells and nanogels larger than 800 nm and crosslinked with more than 10 − 15 mol % BIS were seldom internalized44. Similarly, it was illustrated that the stiffness of PNIPMAM nanogels was the determinant for cellular internalization in 4T1 cancer cells and RAW 264.7 macrophages10. Stiffness-dependent nanogel-organ interactions have also been demonstrated with PNIPAM and PNIPMAM nanogels. Given extreme softness and conformational flexibility, Hendrickson et al. showed PNIPAM nanogels could pass through pores at least tenfold smaller in size under pressures relevant to renal filtration62. For this reason, soft PNIPMAM nanogels achieved deeper penetration within tumor tissue than stiff counterparts10. Another two interesting observations regarding nanogel-organ interactions were reported on PNIPMAM nanogels. First, 15%-crosslinked stiff PNIPMAM nanogels accumulated more and displayed longer retention time in the liver than 2%-crosslinked soft ones, serving as potent blockade agents for temporarily inhibiting reticuloendothelial system (RES) clearance of commercialized nanomedicines such as Doxil and Abraxane. Second, soft nanogels achieved higher tumor targeting delivery efficiency, as exemplified in more tumor accumulation and deeper tumor penetration than stiff ones (Fig. 5)10.Fig. 5Rational utilization of nanogel stiffness for promoted TTDD.The advantages of stiff PNIPMAM nanogels in liver accumulation and inhibition of RES clearance, in synergy with the superior tumor accumulation and penetration of soft nanogels, jointly optimize the antitumor efficacy. Reprinted with permission from ref. 10. Copyright 2023 The Author(s). Rational utilization of nanogel stiffness for promoted TTDD. The advantages of stiff PNIPMAM nanogels in liver accumulation and inhibition of RES clearance, in synergy with the superior tumor accumulation and penetration of soft nanogels, jointly optimize the antitumor efficacy. Reprinted with permission from ref. 10. Copyright 2023 The Author(s). Nanogels with VPT for alternative biomedical applications Interestingly, recent studies revealed that nanogels with VPT produced intrinsic biological effects on mediating cellular behaviors. The first example revealed that the speed of NIH/3T3 cell migration was largely dependent on nanogel softness in PNIPAM nanogels formed 3D tunnel-like structures embedded within fibrin gels63. The second example utilized the increase of temperature to induce the collapse of PNIPAM shell as well as surface functionalized ligands, exerting a mechanical force of 13–50 piconewton per ligand to trigger integrin-initiated focal adhesion maturation and migration of NIH/3T3 cells via surface RGD64. It should be noted that, abovementioned studies focus on temperature above VPTT, while the variation of hydrogen bonds, rearrangement of surface functional groups, and reconstruction of nanogel internal structures occur. As such, nanogels at temperatures above VPTT may activate multiple proteins on cell membranes and intracellular signaling pathways to modulate cellular functions. In contrast to the above mentioned two examples where nanogels exerted biological effects externally, the third example concerned N,N’-bis(acryloyl)cystamine (BAC) crosslinked PNIPMAM nanogels, which modulated cell behaviors from within10. By controlling nanogel softness, 15% crosslinked stiff nanogels produced a more evident suppression of RAW 264.7 phagocytosis in a smaller internalized amount than 2% crosslinked soft counterparts. Besides, PNIPAM nanogels have also been used for applications in detoxification, sepsis therapy, brain ischemic injury, wound management, and cardiac ischemic injury, of which the efficiency may be improved by regulating nanogel VPT65–69. Collectively, these examples emphasized that nanogel VPT features could be rationally designed and precisely controlled for biomedical applications in TAE and TTDD. Nanogel emerging VPT features with potential biomedical applications As illustrated in Fig. 1, the monomer, comonomer, crosslinker, structure, deuteration, and environmental stimuli of nanogels can be adjusted to shift, sharpen, and broaden the VPT of nanogels because of the variation of intramolecular hydrogen bonds. Although nanogels exhibit unique volume phase transition behavior, it is much more noteworthy that numerous interesting features (minimum values) are present around the VPTT during the VPT process70–72. Such minimum values make a contribution to precise nanomedicine design and specific biomedical applications (Fig. 6).Fig. 6The application prospect of the minimum values of nanogel physicochemical properties around VPTT in TAE and TTDD.In detail, the minimum and K of nanogels contribute to sufficient embolization in TAE therapy for solid tumors. The minimum E of nanogels plays a significant role in overcoming tumor ECM for effective TTDD and evading nonspecific accumulation in normal tissues. The minimum γ of Pickering emulsions also exhibits great potential in the optimization of both TAE and TTDD. The application prospect of the minimum values of nanogel physicochemical properties around VPTT in TAE and TTDD. In detail, the minimum and K of nanogels contribute to sufficient embolization in TAE therapy for solid tumors. The minimum E of nanogels plays a significant role in overcoming tumor ECM for effective TTDD and evading nonspecific accumulation in normal tissues. The minimum γ of Pickering emulsions also exhibits great potential in the optimization of both TAE and TTDD. The ratio of radius of gyration to hydrodynamic radius of nanogels exhibits a minimum value around VPTT. The ratio of Rh and Rg, radius of gyration, which is defined as the mass-weighted average distance from the core of a molecule to each mass element in the molecule, reflects the conformation variation of polymer chains and nanogels during VPT3. Wu et al. elegantly demonstrated a minimum value around LCST in an extremely diluted PNIPAM polymer solution. In 2021, Monte et al. illustrated that minimum values existed in numerous PNIPAM nanogels near VPTT, which could be tuned by changing the amount of crosslinkers or initiators during nanogel preparation70. Moreover, different densities of the nanogel core-shell led to inconsistent shrinkage ratios. In detail, dense core fuzzy shell nanogels and fuzzy core dense shell nanogels might exhibit distinct deformability and varied . Peripheral charges as another potential factor provided feedback for electrostatic interactions among surface polymer chains, in concert with other internal interactions such as hydrophilicity and network rigidity, leading to more complicated VPT behavior of nanogels. Furthermore, when nanogel dispersion was concentrated, the squeezing, faceting and interpenetration among nanogels would also be affected by peripheral charges14, leading to varied . Meanwhile, nanogels present the minimum K and E around VPTT. Normally, the elasticity of a material is quantified by its elastic moduli, including K, E, and shear modulus (G)27. Suerra-Martin et al. measured K of PNIPAM and poly (vinyl pyridine) nanogels and found that K of PNIPAM-polyethylene glycol nanogels exhibited a minimum value around VPTT (32 °C), a phenomenon that could be captured with Flory’s theory71. However, individually considering K of the core or shell is far from sufficient because the covalent connection of polymer chains will largely affect the K of the nanogel. So, it is necessary to investigate and establish the correlation among K of core, K of shell and K of nanogel particle for the precise design of nanogels. Because cell functions such as proliferation, migration and metastasis are significantly affected by external mechanical stimulation, addressing these issues has significant implications for understanding the relationship between rheological properties of nanogel suspensions and biological effects in TAE and TTDD for augmented antitumor efficacy73,74. Interestingly, Hashmi et al. demonstrated that PNIPAM nanogels manifested a minimum E of 3 kPa around VPTT (~ 37 °C), whereas nanogels had a higher E of 123 kPa in the collapsed state and 13 kPa in the swollen state72. A similar trend was also documented by Burmistrova et al. with poly(N-isopropylacrylamide-co-acrylic acid) nanogels75. The softened nanogels might increase penetration within solid tumors, which are abundant with extracellular matrix (ECM) and stroma cells27,76. Thus, nanogels with VPTT around 37 °C and the minimum E might make the greatest contribution to TTDD by overcoming tumor pathological barriers such as excessive ECM (Fig. 6). In nanogel-stabilized emulsions, the minimum interfacial tension was revealed around VPTT. Since 2005, PNIPAM nanogels at liquid/liquid interfaces have been leveraged to stabilize Pickering emulsions, the stability of which can be disrupted by raising the temperature above VPTT77. Li et al. systemically investigated adsorption kinetics with PINPAM nanogels at the heptane/water interface78 and observed a minimum interfacial tension (γ) around 35 °C79. Li et al. further revealed that the elastic modulus of nanogels-covered heptane/water interface manifested a minimum value at 35 °C, whereas the loss modulus hardly changed across VPTT. It is highly possible that above, below and around VPTT, PNIPAM nanogels adopt three distinctive conformations, which dictate the interactions between adjacent nanogels, packing of a layer of nanogels, and interfacial tensions at interfaces14,25,26,79. Confirming this conjecture has critical implications for uncovering the destabilization mechanism of PNIPAM nanogels stabilized Pickering emulsions, which find wide biomedical applications. SNG stabilized Pickering emulsion droplets, via pH-triggered adaptive hydrophobicity, demulsified in acidic TME and released the encapsulated drugs to suppress 4T1 tumors80. Iodinated poppy seed fatty acid esters were stabilized with core-shell structured hairy PNIPAM-based nanogels, which underwent a thermal-induced sol-gel transition, achieving excellent embolization and long-term X-ray imaging81. Furthermore, nanogels with VPTT around body temperature will endow Pickering emulsion droplets with the minimum γ during blood circulation of TTDD or transcatheter injection of TAE. Subsequently, the γ of the emulsion droplet increased after stimuli by the tumor acidic environment, which decreased nanogel VPTT, activating the drug release or arterial embolization and decreasing the risk of side effects (Fig. 6). Outlook Nanogels with VPT have been applied to distinct biomedical applications, including TAE therapy, tumor targeting delivery, and alternative biomedical applications. Although notable progress has been made, many challenges and opportunities lie ahead. First, leveraging nanogel VPT features for biomedical applications needs strengthening. Volume change across nanogel VPTT has been exploited to exert mechanical force for focal adhesion formation, cell migration, and T cell receptor activation, but this volume variation has not been utilized for regulating cellular functions such as endocytosis, stemness of tumor cells, antigen presentation of dendritic cells, polarization of macrophages, and so on. Furthermore, new nanogels with VPT in response to pathological clues, such as TME abnormalities, should be pursued. Besides the pH distinction in acidic TME, other pathological clues, such as redox, enzymes, metabolites, and reactive oxygen species, could be used to trigger nanogel VPT53,55. Second, characterizing nanogel biology, including biomacromolecules, cells, and organs, interfaces across nanogel VPTT in situ with the most cutting-edge techniques might provide valuable information for designing more efficient biomedical applications. Although nanogel VPT behaviors have been thoroughly investigated in solution and different interfaces, nanogel VPT behaviors might be more complicated in a biological milieu. For instance, distinctive observations had been reported on PNIPAM nanogels self-assembled on giant unilamellar vesicles below and above nanogel VPTT82. While the interaction potentials between adjacent nanogels in bulk solution and at liquid/liquid as well as liquid/air interfaces are far from comprehension, the interaction force between nanogels, which are decorated with protein coronas, might be even more complex. Third, the VPT induced by temperature or other environmental stimuli always leads to distinct physicochemical properties of nanogels, especially changes in size and volume. The softness of nanogels might also determine the morphology or volume variation when the nanogels are affected by mechanical forces from tissues or cells. Such force-induced transition further affects the distribution of functional groups within nanogels and their interactions with biology. Inspired by nanogels with different monomers forming distinctive protein coronas, nanogels with varied softness will expose different densities of surface functional groups or charges, potentially adsorbing varied proteins or biomacromolecules83–85. Likewise, softness will affect nanogel deformability during the cell membrane wrapping process, resulting in varied interactions between nanogels and membrane proteins to initiate distinct signal pathways and cellular activities, including endocytosis, proliferation, migration, and so on. Fourth, machine learning offers a possible solution to design nanogels with optimized VPT toward tailored biomedical applications. Evolution-based approaches and iterative screening processes have been employed to optimize PNIPAM nanogels67,68. Machine learning might accelerate the preparation of nanogels with tailored VPT in replacement of high-throughput screening86. However, the determinants in different applications might be varied. Thus, a priori knowledge of nanogel-biology interactions is essential and could be obtained from establishing a small library of nanogels29,67,87. Machine learning might also help establish nanogels’ complicated internal structures, including concentration and configuration of different monomers from the nanogel periphery to core, which were closely associated with nanogels’ physicochemical properties, such as size, morphology, and softness. Furthermore, the nanogel-cell or nanogel-organ interaction may be predicted. Finally, potential obstacles and issues in the bench-to-bed translation of nanogels with VPT need to be taken into consideration. PIB nanogel involves three components for preparation, i.e., NIPAM, BMA, and BIS, with advantages of quality control, manufacturing scalability, reproducibility, and regulations, holding great potential to be developed as a class-Ⅲ medical device for TAE therapy. However, numerous issues need to be addressed. Although PNIPAM chains are biocompatible, the monomer NIPAM was revealed to be toxic88. Therefore, an extremely high requirement for detecting and separating unpolymerized NIPAM is essential, which is not a trivial issue in scale-up production. Since PIB nanogel is crosslinked by nondegradable BIS, long-term toxicity is also a big concern. Regarding the application as a carrier for drug delivery, some nanogels are crosslinked by degradable crosslinker BAC, which has a disulfide bond and can be cleaved by endogenous glutathione. Given the porous nature of the crosslinked polymer network, there might be a trade-off between nanogel VPT and drug encapsulation or release. To fully leverage nanogel VPT and precisely control drug release for specific diseases, uncovering molecular interactions and spatial distribution within nanogels below and above VPTT bears significant implications and is still at an initial stage of comprehension. From the translational perspective, nanogels with VPT encounter numerous challenges in manufacturing scalability, reproducibility, quality control, and regulations for systemic administrations, such as hemostatic materials for bleeding management89. Supplementary information Supplementary Information Supplementary Information